Spaces:
Build error
Build error
File size: 174,286 Bytes
c13b805 |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 1813 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 1824 1825 1826 1827 1828 1829 1830 1831 1832 1833 1834 1835 1836 1837 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 1867 1868 1869 1870 1871 1872 1873 1874 1875 1876 1877 1878 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 2260 2261 2262 2263 2264 2265 2266 2267 2268 2269 2270 2271 2272 2273 2274 2275 2276 2277 2278 2279 2280 2281 2282 2283 2284 2285 2286 2287 2288 2289 2290 2291 2292 2293 2294 2295 2296 2297 2298 2299 2300 2301 2302 2303 2304 2305 2306 2307 2308 2309 2310 2311 2312 2313 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 2413 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 |
{
"problem_graph": [
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb750",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"location",
"amount of fluid",
"length"
],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb749",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "an array of needles is incorporated into a device which delivers a substantially equal amount of fluid at any location in said solid tissue along each needle 's length",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb744",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"fluorescence intensity"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the fluorescence values of the reagent blank were subtracted from that of each of the samples and the percentage of free modified rna was determined by dividing the fluorescence intensity of the intact sample ( without addition of triton x-100 ) by the fluorescence value of the disrupted sample ( caused by the addition of triton x-100 )",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb796",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb795",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple needles are incorporated into the instrument which injects fluids intradermally with a wider disperse",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7100",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb799",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to deem",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb782",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb781",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to chiu",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7108",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "approaches can increase the avidity and specificity of homing interactions",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb752",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb751",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple needles are incorporated into a device which delivers a medication into a stratum corneum through the needles",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb798",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb797",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple needles having side openings for enhanced administration are incorporated into a device which by extending and retracting said needles from and into the needle chamber forces a medicinal agent from a reservoir into said needles and injects said medicinal agent into a target organ",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7129",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "prior to injection mmrna-containing lipidoid formulations are diluted in pbs",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb736",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "fusion proteins the modified nucleic acids and mmrna may encode a fusion protein",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb796",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb795",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to eliscu",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb778",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb777",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple hypodermic needles are incorporated into the device which injects the contents of the hypodermics into a tissue as said hypodermics are being retracted",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7102",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7101",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to down",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb732",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb731",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "it will be at least about amino acid residues long",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb788",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb787",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "at least hollow micro-needle is incorporated into the device which delivers the vaccines to the subject 's skin to a depth of between 0.025 mm and 2 mm",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb756",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "modulation of biological pathways the rapid translation of modified mrnas introduced into cells provides a desirable mechanism of modulating target biological pathways",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb756",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"rate"
],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb755",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple needles were incorporated into the pump which pushes a medicating agent through the needles at a controlled rate",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb750",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb749",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to bahrami",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb737",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the supernatants were harvested after hrs and the secreted g-csf protein was analyzed by elisa using the human g-csf elisa kit ( life technologies )",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb748",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb747",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to zimmerman",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb782",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"factor",
"length"
],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb781",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "5 to 15 needles having a maximum diameter of at least 1.25 mm and a length effective to provide a puncture depth of 6 to 20 mm are incorporated into a device which inserts into proximity with a myocardium and supplies an exogeneous angiogenic or myogenic factor to said myocardium through the conduits which are in at least some of said needles",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7103",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"administration of factor ix mmrna",
"pg/ml of factor ix"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the results revealed that administration of factor ix mmrna resulted in levels of 1600 pg/ml at hours as compared to less than pg/ml of factor ix for either luciferase or buffer control administration",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb782",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "in vivo formulation may require the addition of extra ingredients to facilitate circulation throughout the body",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "problem"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb755",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"body weight of the animal"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the dose of the mmrna administered to the animal is calculated depending on the body weight of the animal",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb794",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb793",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple needles are incorporated into the device which is implanted along with one or more housings adjacent the patient 's left and right corpora cavernosa",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7114",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"set ratio"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "example formulation of modified mrna using lipidoids modified mrnas ( mmrna ) are formulated for in vitro experiments by mixing the mmrna with the lipidoid at a set ratio prior to addition to cells",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb754",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb753",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "apoptosis can be induced by multiple independent signaling pathways that converge upon a final effector mechanism consisting of multiple interactions between several \u201c death receptors \u201d and their ligands",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb768",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb767",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple needles are incorporated into the device which moves the attached capsules between an activated position and an inactivated position to force the agent out of the capsules through the needles",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb753",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "from the whole body images the bioluminescence was measured in photon per second for each route of administration and dosing regimen",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7100",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "luciferin was administered by intraperitoneal injection ( ip ) at mg/kg to each mouse prior to imaging during the plateau phase of the luciferin exposure curve which was between and minutes",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb798",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb797",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to ting",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7136",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"room temperature"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the rna vial was then mixed with the rnaimax\u2122 vial and incubated for minutes at room temperature before being added to the cells in a drop-wise fashion",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7106",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "absence may be due to genetic mutation of the encoding gene or regulatory pathway thereof",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb758",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb757",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to toubia",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7102",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7101",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple skin penetrating members which are incorporated into the device have lengths of about microns to about microns and are about 30 to 50 gauge",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7106",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "transformations are performed according to neb instructions using 100 ng of plasmid",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb760",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"number",
"number of neutrons",
"mass"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "\u201c isotopes \u201d refers to atoms having the same atomic number but different mass numbers resulting from a different number of neutrons in the nuclei",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb742",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb741",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"activity level"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "reduction can be measured by expression or activity level of type interferons or the expression of interferon-regulated genes as the toll-like receptors ( e. g",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7130",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "tissue images and serum was collected from each mouse hours after dosing",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7126",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "a reservoir and a pump are also implanted to supply drugs through the needles",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb743",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "subsequently the target compound was subjected to an additional rp-hplc purification which was done using a ymc\u2014pack c4 column to afford the target compound",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb756",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb755",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according shachar",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7109",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "one of ordinary skill in the art will appreciate that the nucleotide analogs or other modification ( s ) may be located at any position ( s ) of a nucleic acid such that the function of the nucleic acid is not substantially decreased",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7105",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "results were interpolated against the standard curve of each elisa plate using a four parameter logistic curve fit",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7139",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"ability"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "\u201c proliferative \u201d means having the ability to proliferate ",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb758",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb757",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple needles are incorporated into the probe which receives the active agent into a chamber and administers the agent to the tissue",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb766",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb765",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple needles are incorporated into the devices which deliver the therapeutic agents to different depths within the tissue",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb752",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "an asterisk indicates statistical significance at p < 0.001 compared to buffer",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb798",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "also provided are nucleic acids containing a kozak sequence",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb767",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "all statements as to the date or representation as to the contents of these documents is based on the information available to the applicants and does not constitute any admission as to the correctness of the dates or contents of these documents",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb746",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb745",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "micro-needles are incorporated into a device which drives by an electrical current the medication through the needles into the targeted treatment site",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb754",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "many chemical cap analogs are used to co-transcriptionally cap a synthetic mrna molecule",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb752",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb751",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to kimmell",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb780",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb779",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to pettis",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb766",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb765",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to orr",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb774",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"energy"
],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb773",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple needles are incorporated into a device which applies vacuum to draw skin into contact with a plate so that needles insert into skin through the holes on the plate and deliver rf energy",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb746",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb745",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to etheredge",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb788",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb787",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to mitszta",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb776",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb775",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple needles are incorporated into a device which is inserted into a body and delivers a medication fluid through said needles",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb768",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "these complexes require the dicer ribonuclease and clr4 histone h3 methyltransferase for activity",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "problem"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb795",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the bioluminescence showed a positive signal at the injection site of the 5 \u03bcg and \u03bcg modified rna formulations containing and not containing lipoplex",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb784",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb783",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "delivery may be at the same time",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb793",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "rnaimax\u2122 example routes of administration further studies were performed to investigate dosing using different routes of administration",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb786",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb785",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "an array of micro-needles is incorporated into a device which delivers a therapeutic agent through the needles directly into the trigone of the bladder",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb790",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"effect"
],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb789",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the cytotoxic nucleosides are released which also effect therapeutic benefit to the subject",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb774",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb773",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to schomacker",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb764",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb763",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to angel",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7124",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "example in vivo delivery using varying lipid ratios modified mrna was delivered to c57/bl6 mice to evaluate varying lipid ratios and the resulting protein expression",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb778",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb777",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to zamoyski",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb780",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb779",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple needles are incorporated into a device which delivers the substance through the needles to a depth between 0.3 mm and 2 mm",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb776",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb775",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to desai",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7122",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "example in vitro transcription ( ivt ) the in vitro transcription reaction generates mrna containing modified nucleotides or modified rna",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7100",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb799",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple needles are incorporated into the device which delivers neurotoxin through the needles into the bronchial tissue",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7137",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the liver and spleen from the mice administered with mcherry modified mrna are analyzed by immunohistochemistry ( ihc ) or fluorescence-activated cell sorting ( facs )",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb770",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb769",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "curved needles are incorporated which enter the organ wall in a flattened trajectory",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb794",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb793",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to forsell",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb770",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"effect"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the functions may effect the same outcome or a different outcome",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb738",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"factor ix protein"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the results demonstrate that factor ix protein was elevated in serum as measured hours after administration",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb791",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"weight polyethylene"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "solid compositions of a similar type may be employed as fillers in soft and hard-filled gelatin capsules using such excipients as lactose or milk sugar as well as high molecular weight polyethylene glycols and the like",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7116",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"room temperature"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the diluted components are pooled and incubated minutes at room temperature before they are dispensed to culture media",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7119",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"fluorescence intensity"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the mean fluorescence intensity ( mfi ) of all events and the standard deviation of four independent wells are presented in for samples analyzed",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb786",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb785",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to versi",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7117",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"density",
"cell density"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "cell density may vary from cell/50 \u03bcl to a density of 2.5\u00d7106 cells/50 \u03bcl and require from 110v to 145v to transfect cells with similar efficiencies measured in transcript copies per cell",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "problem"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb792",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb791",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "it is known to be difficult to obtain dna expression in cells as frequently dna enters a cell but is not expressed or not expressed at reasonable rates or concentrations",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb759",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "also provided are compositions for generation of an in vivo depot containing an engineered ribonucleotide",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb789",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "techniques for determining identity are codified in publicly available computer programs",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb760",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb759",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "as it pertains to a modified mrna may also mean any alteration which is different from the wild type",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb768",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb767",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to gunday",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb748",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"content in a reservoir"
],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb747",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple hollow needles positioned in a roller are incorporated into the device which delivers the content in a reservoir through the needles as the roller rotates",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb764",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"substance into a body surface",
"surface"
],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb763",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "multiple needles are incorporated into the device which transports a substance into a body surface through the needles which are inserted into the surface from different directions",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb786",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "different nucleotide modifications and/or structures may exist at various positions in the nucleic acid",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb780",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the formulations which had been purified had a slightly higher mfi than those formulations tested before purification",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb762",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"parents": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb761",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "a ligand can act as a homing moiety which permits the cell to target to a specific tissue or interact with a specific ligand",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb770",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb769",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "according to tkebuchava",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb771",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "final reaction concentrations for nucleotide are mm for the cap analog and 1.5-7.5 mm for each of the other nucleotides",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb7132",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "\u201c anti-proliferative \u201d means having properties counter to or inapposite to proliferative properties",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb747",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "approaches can increase the avidity and specificity of homing interactions",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb757",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [
"matrix into the blood stream",
"ability of formulations"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the characteristics of optimized lipidoid formulations for intramuscular or subcutaneous routes may vary significantly depending on the target cell type and the ability of formulations to diffuse through the extracellular matrix into the blood stream",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb732",
"id": "d7c91fb6-1548-4c73-a2c0-bc6c60b23eb731",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the polypeptide is a peptide",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "cc9d3b3d-3653-4ae3-aa77-584093cd2cb850",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the mmrna comprises the modified nucleoside 1-methyl-pseudouridine in combination with 5-methyl-cytidine",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f159",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [
"level"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "solid and hematopoietic tumor types are particularly associated with a high level of abnormal angiogenesis",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f135",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [
"concentration"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "specific sirna and concentration are indicated for each plot",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f173",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "coupling to peg was performed at c. for hours in fold molar excess of reactive linear peg unless otherwise indicated",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f161",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "receptors which interact preferentially with ephrin-a proteins are epha receptors and those which interact preferentially with ephrin-b proteins are ephb receptors",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f165",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "g. ephb4 sirna and antisense odns inhibit the mobility of pc3 cells pc3 cells can grow aggressively locally and can form lymph node metastases when injected orthotopically into mice",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f195",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "twenty prospectively collected tumor tissues following irb approval have been evaluated with specific ephb4 monoclonal antibody that does not react with other members of the ephb and epha family",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f1129",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "we investigated whether ks tumor cells are derived from arterial or venous endothelium",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f196",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "shown are merged images of dapi and fitc fluorescence",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f172",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "shown are representative phase contrast fields of cord formation after hr plating on matrigel\u2122 in the continued presence of the test compounds as shown",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f191",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "results of three independent experiments are shown for each protein",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f1126",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the soluble ephb4 polypeptide may inhibit clustering of or phosphorylation of ephrin b2 or ephb4",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f160",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [
"concentration"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "i. purification of pegylated sb4 species biotinylated sb4 protein was concentrated up to final concentration of 2 mg/ml using a 30 kda mwco ultra membrane",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f148",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the soluble ephrinb2 polypeptides bind specifically to an ephb4 polypeptide",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "b5eaaee4-ba92-4c10-abd8-c882f30706f162",
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f161",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the subsequent vascular response was measured extending from the limbal vasculature toward the pellet and the contiguous circumferential zone of neovascularization data and clinical photos presented here were obtained on day after pellet implantation",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f160",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"parents": "b5eaaee4-ba92-4c10-abd8-c882f30706f159",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "reverse signaling can occur through the ephrin bs",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "problem"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f170",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "shown are representative photomicrographs of control sirna and sirna treated cells",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f1111",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "growth inhibition assay human umbilical cord vein endothelial cells ( huvec ) ( 1.5\u00d7103 ) are plated in a 96-well plate in \u03bcl of ebm-2 ( clonetic # cc3162 )",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "b5eaaee4-ba92-4c10-abd8-c882f30706f158",
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f157",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [
"ingredient",
"amount",
"dosage form"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the amount of active ingredient which can be combined with a carrier material to produce a single dosage form will vary depending upon the host being treated",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f1127",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "shown are the mean+standard deviation of duplicate samples",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f141",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "at nm there was times more apoptosis in sirna transfected than control sirna transfected pc3 cells",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f162",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "murine matrigel plug angiogenesis assay in vivo angiogenesis was assayed in mice as growth of blood vessels from subcutaneous tissue into a matrigel plug containing the test sample",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f163",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "slk cells transfected with lana or lana\u03b4440 are slk-lana and slk-\u03b4440 respectively",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f190",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the soluble ephb4 polypeptides bind specifically to an ephrinb2 polypeptide",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "b5eaaee4-ba92-4c10-abd8-c882f30706f160",
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f159",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "in addition to forward signaling through the eph receptor",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f158",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "photomicrographs are of representative fields ",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f1138",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "shown are photomicrographs of representative fields taken immediately after the scrape was made in the monolayer ( 0 h ) and after 20 h continued culture",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f155",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "binding reactions were stopped by dilution with 1.2 ml of bb and centrifugation",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "b5eaaee4-ba92-4c10-abd8-c882f30706f142",
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f141",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [
"length of the linker sequence",
"length"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the length of the linker sequence separating ephb4 and hsa can be from 5 to 500 amino acids in length",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f1113",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "mice are sacrificed on day 14",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f1119",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "several clinical problems regarding the diagnosis and treatment of malignant mesothelioma remain unsolved",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f176",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the differences between normal epithelium of the upper aerodigestive tract and cancer cells arising from that tissue are the result of mutations in specific genes and alteration of their expression",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f1133",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [
"number",
"efficacy",
"region"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "a number of different phosphorothioate-modified as-odns complementary to different segments of the ephb4 coding region were tested for specificity and efficacy of ephb4 inhibition",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f154",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "cotransfection of hhv-8 vgpcr induces ephrin b2 transcription approximately 10-fold compared to the control expression vector pcefl",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f165",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "polypeptides may also inhibit angiogenesis in vivo or in an cell-based assay system",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f1131",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the polypeptide can then be reacted with chemical protecting agents to selectively protect reactive side chain groups and thereby prevent side chain groups from being modified",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f183",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "ephb4 antibodies mg per kg body weight were administered",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "problem"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f170",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "modified soluble polypeptide are considered functional equivalents of the naturally-occurring ephb4 or ephrin b2 soluble polypeptide",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f1122",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "pegs with more than peg chain are called multiarmed or branched pegs",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f1128",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "a ) in situ hybridization with antisense probes for ephrin b2 and ephb4 with corresponding h & e stained section to show tumor architecture",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f136",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "applicants detected expression of ephrin b2 and ephb4 in tumor tissues and developed anti-tumor therapeutic agents for blocking signaling through the ephrin/eph",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "b5eaaee4-ba92-4c10-abd8-c882f30706f132",
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f131",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "it is expected that dna sequence polymorphisms that do lead to changes in the amino acid sequences of the subject proteins will exist among mammalian cells",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f194",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "shown are the mean+s e. m. of 6 mice/group ",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f151",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "stroma and the normal epithelia are negative",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f197",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "specific signal for ephb4 was detected using antisense probe ephrin b2 transcripts were also detected in the same cell line",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f1134",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "an intrastromal micropocket was dissected using a modified von graefe knife ( 2\u2022\u202230 mm )",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "b5eaaee4-ba92-4c10-abd8-c882f30706f164",
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f163",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [
"number of cells"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "a large number of cells have filled in the scrape after 20 h with control sirna",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f142",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "masson 's trichrome allows to visualize necrosis and fibrosis",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f143",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "results obtained from experiments with duplicate plugs are displayed as mean values\u00b1s",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f177",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [
"propidium iodide fluorescence intensity",
"cell number"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "shown are the plots of cell number vs. propidium iodide fluorescence intensity ",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f134",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the right hand column are frozen sections of lymph node metastasis stained with ephb4 polyclonal antibody ( top right ) and visualized with dab",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f164",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "results are displayed as mean values\u00b1s",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "b5eaaee4-ba92-4c10-abd8-c882f30706f154",
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f153",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [
"domain"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "sequence of the extracellular domain of human ephb4 contains predicted n-glycosylation sites ( nxs/t ) which are located in the cys-rich domain",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f192",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "shown are membranes sequentially probed for ephb4 and \u03b2-actin",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f168",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "polypeptides may also inhibit angiogenesis in vivo or in an cell-based assay system",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f157",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "examples are salicylic acid and sulfur",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "b5eaaee4-ba92-4c10-abd8-c882f30706f166",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "a displays the strong inhibition of tubule formation by b4v3 in a representative experiment",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a781",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "persons of ordinary skill in the art can easily estimate repetition rates for dosing based on measured residence times and concentrations of the drug in bodily fluids or tissues",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a758",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "southern blots are performed to allow a determination of the degree of identity between genes in target species and other species",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a789",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "variants that originate from a pre-mrna or mrna that use alternative start codons are known as \u201c alternative start variants of that pre-mrna or mrna",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a785",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [
"conformation",
"temperature"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "melting curve assay determines the temperature at which a rapid transition from double-stranded to single-stranded conformation occurs for the natural antisense/molecule complex",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a770",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the abstract of the disclosure will allow the reader to quickly ascertain the nature of the technical disclosure",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a782",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the amide backbones disclosed by de mesmaeker et al ",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a742",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"parents": "4e1c30c9-36d0-4bf7-811d-21c12fae31a741",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "adenine and thymine are complementary nucleotides which pair through the formation of hydrogen bonds",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a750",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "cardiomyopathics may result from a lack of oxygen",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a766",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "\u201c segments \u201d are defined as smaller or sub-portions of regions within a target nucleic acid ",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a763",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "real time pcr results show that the levels of dmd family mrna in cells are significantly increased 48 h after treatment with of the sirnas designed to dmd family antisense bg208074",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a747",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "comparison of nucleic acid sequences from a range of species allows the selection of nucleic acid sequences that display an appropriate degree of identity between species",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a747",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "binding occurs through the target binding portion of an enzymatic nucleic acid this/these is held in close proximity to an enzymatic potion of the molecule that acts to cleave the target rna",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a771",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "these findings demonstrate that ribozymes can promote chemical transformations with catalytic rates that are significantly greater than those displayed in vitro by most natural self-cleaving ribozymes",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a788",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "liposomes that are ph-sensitive or negatively-charged are believed to entrap dna rather than complex with it",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a742",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "an antisense oligonucleotide can upregulate or downregulate expression and/or function of a particular polynucleotide",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a749",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "binding occurs through the target binding portion of a enzymatic nucleic acid this/these is held in close proximity to an enzymatic portion of the molecule that acts to cleave the target rna",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a787",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "variants may result from at least mutation in the nucleic acid sequence and may result in altered mrnas or in polypeptides whose structure or function may or may not be altered",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a7106",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the development of ribozymes that are optional for catalytic activity would contribute significantly to any strategy that employs rna-cleaving ribozymes for the purpose of regulating gene expression",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a784",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [
"form of heart disease"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "mutations in the dmd family gene also cause a form of heart disease called x-linked dilated cardiomyopathy",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a765",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "no splicing of the pre-mrna variant occurs then the pre-mrna variant is identical to the mrna variant",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a792",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "\u201c neurological disease or disorder \u201d refers to any disease or disorder of the nervous system and/or visual system ",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a798",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "binding occurs through the target binding portion of a enzymatic nucleic acid which is held in close proximity to an enzymatic portion of the molecule that acts to cleave the target rna",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "4e1c30c9-36d0-4bf7-811d-21c12fae31a746",
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a745",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "in addition to aiding the diffusion of non-lipophilic drugs across cell membranes",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a764",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [
"form of droplets"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "emulsions are typically heterogeneous systems of one liquid dispersed in another in the form of droplets usually exceeding 0.1 \u03bcm in diameter",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a753",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "moieties include but are not limited to lipid moieties as a cholesterol moiety, a cholesteryl moiety ( letsinger et al ., proc",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a754",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [
"ability"
],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "strategic cleavage of such a target rna will destroy its ability to direct synthesis of an encoded protein",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "problem"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a744",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"parents": "4e1c30c9-36d0-4bf7-811d-21c12fae31a743",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the activity or expression of dystrophin family in an animal is inhibited by 50 % or more",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a752",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "cleavage event renders the mrna non-functional and abrogates protein expression from that rna",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a760",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the specificity and sensitivity of antisense are also harnessed by those of skill in the art for therapeutic uses",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a799",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "species variants are polynucleotide sequences that vary from species to another",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a737",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "binding occurs through the target binding portion of an enzymatic nucleic acid which is held in close proximity to an enzymatic potion of the molecule that acts to cleave the target rna",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a786",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "other diseases include those that result from myocardial injury which involves damage to the muscle or the myocardium in the wall of the heart as a result of disease or trauma",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"enfants": "4e1c30c9-36d0-4bf7-811d-21c12fae31a732",
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a731",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "new isoforms of syntrophins ( \u03b31- and \u03b32- ) have also been reported and were found expressed as brain-specific protein ( piluso et al ",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "partialSolution"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a746",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [
"permeability"
],
"parents": "4e1c30c9-36d0-4bf7-811d-21c12fae31a745",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "penetration enhancers also enhance the permeability of lipophilic drugs",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a740",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "the decoy rna therefore competes with natural binding target for the binding of a specific ligand",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{
"concept": {
"id": "4e1c30c9-36d0-4bf7-811d-21c12fae31a748",
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"parameters": [],
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"sentence": "cardiomyopathics may result from a lack of oxygen",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"type": "neutre"
}
},
{}
],
"parameters": [
{
"concept": {
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533047&KC=7",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533047&KC=7&FT=D&ND=3&date=&DB=&locale=en_EP#",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533047.txt",
"valeurs": {
"us9533047-1": "matrix into the blood stream",
"us9533047-10": "substance at a depth",
"us9533047-11": "amount of the mmRNA",
"us9533047-12": "meaning",
"us9533047-13": "wt ratio of lipidoid",
"us9533047-14": "substance at the site",
"us9533047-15": "cell density during electroporation",
"us9533047-16": "amount of mmRNA",
"us9533047-17": "length of the poly",
"us9533047-18": "concentration of the mmRNA",
"us9533047-19": "concentration of a compound",
"us9533047-2": "dosage form",
"us9533047-20": "penetration length",
"us9533047-21": "number of individuals",
"us9533047-22": "variety of factors",
"us9533047-23": "anchor chain length of poly",
"us9533047-24": "energy into skin",
"us9533047-25": "amount of the composition",
"us9533047-26": "fluorescence intensity",
"us9533047-27": "region of the tissue",
"us9533047-28": "length of each gap",
"us9533047-29": "volume scale-up",
"us9533047-3": "form of eye drops",
"us9533047-30": "ratio of the monomers",
"us9533047-31": "form of a compound",
"us9533047-32": "body weight of the animal",
"us9533047-33": "reference point",
"us9533047-34": "number of neutrons",
"us9533047-35": "manufacturing process herein",
"us9533047-36": "substance into an area",
"us9533047-37": "condition of the subject",
"us9533047-38": "ability of the mRNA",
"us9533047-39": "length of the molecule",
"us9533047-4": "gram mouse the volume",
"us9533047-40": "weight ratio",
"us9533047-41": "plasma concentration",
"us9533047-42": "dose/at time/single route/single point of contact",
"us9533047-43": "substance into a body surface",
"us9533047-44": "room temperature for hours",
"us9533047-45": "DNA at some frequency",
"us9533047-46": "cytometer measurement",
"us9533047-47": "receptor on the surface",
"us9533047-48": "form of tablets",
"us9533047-49": "region of a target gene",
"us9533047-5": "molecule in a form",
"us9533047-50": "bar",
"us9533047-51": "concentration of the drug",
"us9533047-52": "amount of fluid",
"us9533047-53": "form of a biomolecule",
"us9533047-54": "concentration of the compound",
"us9533047-55": "mRNA in an injection volume",
"us9533047-56": "room temperature",
"us9533047-57": "number of cells",
"us9533047-58": "ratio of mmRNA",
"us9533047-59": "weight cutoff",
"us9533047-6": "amount of the ribonucleic",
"us9533047-60": "protein with death domain",
"us9533047-61": "indicator of the efficacy",
"us9533047-62": "peach kernel",
"us9533047-63": "ability of these lipidoids",
"us9533047-64": "level of mCherry",
"us9533047-65": "state concentration",
"us9533047-66": "vaccine in powder form",
"us9533047-67": "synthetic mRNA copy number",
"us9533047-68": "stream of propellant",
"us9533047-69": "tumor necrosis factor",
"us9533047-7": "condition for the purpose",
"us9533047-70": "persistence length",
"us9533047-71": "cell surface",
"us9533047-72": "benefit/risk ratio",
"us9533047-73": "effect regulation of transcription",
"us9533047-74": "expression level",
"us9533047-75": "body surface",
"us9533047-76": "communication with a voltage supply",
"us9533047-77": "volume of distribution",
"us9533047-78": "cell-surface receptor",
"us9533047-79": "surface of a cell",
"us9533047-8": "content in a reservoir",
"us9533047-80": "thixotropic amount of a thixotropic agent",
"us9533047-81": "well at a volume",
"us9533047-82": "unit quantity of composition",
"us9533047-83": "growth factor-isoform",
"us9533047-84": "measurement of integrity",
"us9533047-85": "concentration and/or potency",
"us9533047-86": "amount of a composition",
"us9533047-87": "ratio of surface charge",
"us9533047-88": "voltage supply",
"us9533047-89": "protein level in each mouse",
"us9533047-9": "activity level of a Type interferon",
"us9533047-90": "height",
"us9533047-91": "starting point",
"us9533047-92": "level of G-CSF production",
"us9533047-93": "drug form",
"us9533047-94": "splitting factor",
"us9533047-95": "fluorescence intensity of mCherry",
"us9533047-96": "amount of an agent"
}
}
},
{
"concept": {
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533026&KC=6",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533026&KC=6&FT=D&ND=3&date=&DB=&locale=en_EP#",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533026.txt",
"valeurs": {
"us9533026-1": "effect on expression",
"us9533026-10": "difference in body weight",
"us9533026-100": "form of B4v3",
"us9533026-101": "growth factor receptor",
"us9533026-102": "mass for a PEG",
"us9533026-103": "effect on the growth",
"us9533026-104": "tumor weight",
"us9533026-105": "amount of B4EC-FC",
"us9533026-106": "density of microvessels",
"us9533026-107": "drug concentration",
"us9533026-108": "stability of EphB4",
"us9533026-109": "color in the ISH",
"us9533026-11": "stability in vivo",
"us9533026-110": "week treatment period",
"us9533026-111": "volume of distribution",
"us9533026-112": "ratio of drug",
"us9533026-113": "surface of a cell",
"us9533026-114": "well at a volume",
"us9533026-115": "room temperature for minutes",
"us9533026-116": "growth factor-isoform",
"us9533026-117": "weight of the PEG group",
"us9533026-118": "dilution effect",
"us9533026-119": "amount of a composition",
"us9533026-12": "treatment period",
"us9533026-120": "solubility of the polypeptide",
"us9533026-121": "gel at body temperature",
"us9533026-122": "protein level in each mouse",
"us9533026-123": "propidium iodide fluorescence intensity",
"us9533026-124": "form of capsules",
"us9533026-125": "effect of this protein",
"us9533026-126": "portion of a CH3 domain",
"us9533026-127": "amount of a polypeptide agent",
"us9533026-128": "expression pattern",
"us9533026-129": "level of G-CSF production",
"us9533026-13": "effect of B4Ecv3",
"us9533026-130": "drug form",
"us9533026-131": "cell number",
"us9533026-132": "percentage of tumor section area",
"us9533026-133": "length of cords",
"us9533026-134": "region of the tissue",
"us9533026-135": "area of necrosis",
"us9533026-136": "effect of B2EC-FC",
"us9533026-14": "amount of EphB4",
"us9533026-15": "portion of a hinge domain",
"us9533026-16": "content in a reservoir",
"us9533026-17": "activity level of a Type interferon",
"us9533026-18": "surface of the protein",
"us9533026-19": "tumor density",
"us9533026-2": "vivo stability",
"us9533026-20": "number of cells",
"us9533026-21": "release of compounds",
"us9533026-22": "cell density during electroporation",
"us9533026-23": "nomenclature in this area",
"us9533026-24": "wt ratio of lipidoid",
"us9533026-25": "number of HHV-8",
"us9533026-26": "salt concentration",
"us9533026-27": "juxtamembrane region",
"us9533026-28": "length of the poly",
"us9533026-29": "region of tumor cells",
"us9533026-3": "domain of B4",
"us9533026-30": "surface of the filter",
"us9533026-31": "epitope within a junction region",
"us9533026-32": "growth factor",
"us9533026-33": "variety of factors",
"us9533026-34": "anchor chain length of poly",
"us9533026-35": "energy into skin",
"us9533026-36": "presence of growth factors",
"us9533026-37": "ability of the EphB4",
"us9533026-38": "domain of an EphrinB2 protein",
"us9533026-39": "linker sequence length",
"us9533026-4": "level of EphB4 and/or EphrinB2",
"us9533026-40": "fibroblast growth factor",
"us9533026-41": "protein tyrosine kinase domain",
"us9533026-42": "amino acid within the junction region",
"us9533026-43": "area of the wound",
"us9533026-44": "ratio of the monomers",
"us9533026-45": "bone marrow",
"us9533026-46": "body weight of the animal",
"us9533026-47": "growth rate",
"us9533026-48": "form at C.",
"us9533026-49": "number of neutrons",
"us9533026-5": "cell with an amount",
"us9533026-50": "globular domain",
"us9533026-51": "substance into an area",
"us9533026-52": "condition of the subject",
"us9533026-53": "amount of the compound",
"us9533026-54": "ability of the mRNA",
"us9533026-55": "volume of diluent",
"us9533026-56": "release component",
"us9533026-57": "amount of infiltration",
"us9533026-58": "form of PEGs",
"us9533026-59": "ability of the fragments",
"us9533026-6": "dosage form",
"us9533026-60": "cell density",
"us9533026-61": "room temperature for hours",
"us9533026-62": "DNA at some frequency",
"us9533026-63": "cytometer measurement",
"us9533026-64": "domain of an Ephrin B2 protein",
"us9533026-65": "level of skill",
"us9533026-66": "cytotoxic effect at these doses",
"us9533026-67": "Drug effect",
"us9533026-68": "receptor on the surface",
"us9533026-69": "region of a target gene",
"us9533026-7": "ml/fraction with a concentration increment",
"us9533026-70": "mass of PEG",
"us9533026-71": "concentration of the drug",
"us9533026-72": "copy number",
"us9533026-73": "region of an immunoglobulin",
"us9533026-74": "intensity of staining",
"us9533026-75": "Tumor volume",
"us9533026-76": "location of all cells",
"us9533026-77": "region \u201d",
"us9533026-78": "effect of EphB4 siRNA",
"us9533026-79": "reduction in the number",
"us9533026-8": "length of the linker sequence",
"us9533026-80": "room temperature",
"us9533026-81": "unit dosage form",
"us9533026-82": "liquid at body temperature",
"us9533026-83": "growth rate of the tumor",
"us9533026-84": "weight cutoff",
"us9533026-85": "protein with death domain",
"us9533026-86": "peach kernel",
"us9533026-87": "volume of PBS",
"us9533026-88": "sample of the effect",
"us9533026-89": "potency relative",
"us9533026-9": "form of eye drops",
"us9533026-90": "invasion index",
"us9533026-91": "effect of administration",
"us9533026-92": "domain of IgM",
"us9533026-93": "effect of EphB4 AS-10",
"us9533026-94": "vaccine in powder form",
"us9533026-95": "domain of an EphB4 protein",
"us9533026-96": "molar ratio",
"us9533026-97": "full-length",
"us9533026-98": "persistence length",
"us9533026-99": "location"
}
}
},
{
"concept": {
"image": "https://worldwide.espacenet.com/espacenetImage.jpg?flavour=firstPageClipping&locale=en_EP&FT=D&&CC=US&NR=9533004&KC=4",
"pdf": "https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=9533004&KC=4&FT=D&ND=3&date=&DB=&locale=en_EP#",
"source": "/Users/nixin/PycharmProjects/PatentSolver_demonstrator_git/Data/input/US_patents/US9533004.txt",
"valeurs": {
"us9533004-1": "distribution and/or absorption",
"us9533004-10": "effect of B4Ecv3",
"us9533004-100": "form of heart disease",
"us9533004-11": "level of DMD family mRNA",
"us9533004-12": "amount of EphB4",
"us9533004-13": "strength of interaction",
"us9533004-14": "content in a reservoir",
"us9533004-15": "surface of the protein",
"us9533004-16": "tumor density",
"us9533004-17": "release of compounds",
"us9533004-18": "nomenclature in this area",
"us9533004-19": "number of HHV-8",
"us9533004-2": "vivo stability",
"us9533004-20": "juxtamembrane region",
"us9533004-21": "region of the oligonucleotide",
"us9533004-22": "region of tumor cells",
"us9533004-23": "change+standard deviation in UTRN mRNA",
"us9533004-24": "variety of factors",
"us9533004-25": "anchor chain length of poly",
"us9533004-26": "energy into skin",
"us9533004-27": "domain of an EphrinB2 protein",
"us9533004-28": "linker sequence length",
"us9533004-29": "form of a ratio",
"us9533004-3": "binding domain for a ligand",
"us9533004-30": "\u201d meaning",
"us9533004-31": "form of this heart condition",
"us9533004-32": "area of the wound",
"us9533004-33": "bone marrow",
"us9533004-34": "growth rate",
"us9533004-35": "form at C.",
"us9533004-36": "globular domain",
"us9533004-37": "amount of the compound",
"us9533004-38": "start codon region",
"us9533004-39": "volume of diluent",
"us9533004-4": "hybridization rate",
"us9533004-40": "amount of a compound",
"us9533004-41": "amount of infiltration",
"us9533004-42": "ability of the fragments",
"us9533004-43": "cell density",
"us9533004-44": "room temperature for hours",
"us9533004-45": "cytometer measurement",
"us9533004-46": "chemical region",
"us9533004-47": "level of skill",
"us9533004-48": "cytotoxic effect at these doses",
"us9533004-49": "receptor on the surface",
"us9533004-5": "length wherein",
"us9533004-50": "acid concentration",
"us9533004-51": "mass of PEG",
"us9533004-52": "measurement system",
"us9533004-53": "copy number",
"us9533004-54": "region of an immunoglobulin",
"us9533004-55": "Tumor volume",
"us9533004-56": "location of all cells",
"us9533004-57": "region \u201d",
"us9533004-58": "reduction in the number",
"us9533004-59": "room temperature",
"us9533004-6": "ml/fraction with a concentration increment",
"us9533004-60": "duration of action",
"us9533004-61": "stop codon region",
"us9533004-62": "weight cutoff",
"us9533004-63": "stability in the presence",
"us9533004-64": "peach kernel",
"us9533004-65": "effect cleavage",
"us9533004-66": "sample of the effect",
"us9533004-67": "invasion index",
"us9533004-68": "target region",
"us9533004-69": "measure of the interaction strength",
"us9533004-7": "form of eye drops",
"us9533004-70": "effect of EphB4 AS-10",
"us9533004-71": "vaccine in powder form",
"us9533004-72": "domain of an EphB4 protein",
"us9533004-73": "number of nucleotides",
"us9533004-74": "kg of body weight",
"us9533004-75": "effect on the growth",
"us9533004-76": "form of B4v3",
"us9533004-77": "tumor weight",
"us9533004-78": "loss of activity",
"us9533004-79": "density of microvessels",
"us9533004-8": "difference in body weight",
"us9533004-80": "drug concentration",
"us9533004-81": "color in the ISH",
"us9533004-82": "volume of distribution",
"us9533004-83": "length of the target polynucleotide",
"us9533004-84": "well at a volume",
"us9533004-85": "room temperature for minutes",
"us9533004-86": "growth factor-isoform",
"us9533004-87": "g. accession number",
"us9533004-88": "dilution effect",
"us9533004-89": "target region within the target",
"us9533004-9": "treatment period",
"us9533004-90": "gel at body temperature",
"us9533004-91": "propidium iodide fluorescence intensity",
"us9533004-92": "form of capsules",
"us9533004-93": "portion of a CH3 domain",
"us9533004-94": "amount of a polypeptide agent",
"us9533004-95": "expression pattern",
"us9533004-96": "drug form",
"us9533004-97": "cell number",
"us9533004-98": "length of cords",
"us9533004-99": "region of the tissue"
}
}
}
]
} |